(相关资料图) 美银将诺瓦瓦克斯医药的目标价从9美元下调至7美元，评级从"中性"下调至"跑输大市"。(格隆汇) 相关事件 美银下调诺瓦瓦克斯医药目标价至7美元花旗首予诺瓦瓦克斯医药"卖出"评级及目标价6美元 标签： ...

Group 1 - The stock of the company, CSPC Pharmaceutical Group, fell over 5%, marking the largest decline in three weeks [1] - Jefferies downgraded the stock rating to "underperform," indicating that all positive factors have already been reflected in the stock price [1] - The company continues to face sales challenges for key products [1]